Simplex Trading’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-60
Closed -$7K 7229
2017
Q3
$7K Sell
60
-313
-84% -$3.51K ﹤0.01% 4178
2017
Q2
$46K Buy
373
+293
+366% +$2.99K ﹤0.01% 2475
2017
Q1
$9K Sell
80
-208
-72% -$2.41K ﹤0.01% 4126
2016
Q4
$33K Buy
288
+249
+638% +$3.47K ﹤0.01% 2587
2016
Q3
$2K Sell
39
-113
-74% -$1.33K ﹤0.01% 5162
2016
Q2
$19K Sell
152
-2
-1% -$22 ﹤0.01% 2968
2016
Q1
$29K Buy
154
+143
+1,300% +$1.81K ﹤0.01% 2471
2015
Q4
$6K Sell
11
-70
-86% -$1.25K ﹤0.01% 3805
2015
Q3
$19K Buy
81
+34
+72% +$779 ﹤0.01% 2872
2015
Q2
$6K Buy
+47
New +$815 ﹤0.01% 3593

Other funds holding SCMP

Simplex Trading's SCMP Position: Q1 2018 in Review

Simplex Trading sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 21,200 shares — an estimated $380K sold.

Simplex Trading first reported a position in SCMP in Q4 2014 and held it in 10 quarters. The position peaked at $380K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Simplex Trading reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Simplex Trading sold 21,200 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $380K.
  • Simplex Trading first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 10 quarters.
  • Simplex Trading's Sucampo Pharmaceuticals, Inc. position peaked at $380K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Simplex Trading's 13F filing for Q1 2018, filed 26 Apr 2018.